Drug Allergy Market Research Report - Global forecast till 2023 Drug allergy market information: by type (immunologic, nonimmunologic, and others), diagnosis (skin tests, blood tests, and others), by treatment (antihistamines, corticosteroids, and others), by end user- global forecast till 2023
Market Research Future Publish a New Report on - “Drug Allergy Market Research Report Global forecast till 2023� Exclusive Summery About Report: The global drug allergy market is growing moderately and it is expected to grow with the same pace over the forecast period 2017-2018. Increasing prevalence of drug allergies and funding for research & development of the new drugs drive the global market. The global market of drug allergy was around USD 3363.2 million in 2016 and is expected to reach USD 4764.0 million by 2023 at a projected CAGR of 5.1%. Drug Allergy Market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including AstraZeneca (UK), Bayer (US), Circassia (US), HAL Allergy Group (the Netherlands) Johnson & Johnson Services, Inc. (US), MAGNA Pharmaceuticals, Inc. (US), Stallergenes Greer (UK) and others. Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/4033 Regional Analysis The global drug allergy market is consist of four regions: America, Europe, Asia Pacific, and the Middle East & Africa. Increasing funding for R&D, and ongoing clinical trials of various drugs are driving the growth for the America drug allergy market. The Americas market is consist of North America and Latin America. The drug allergy is one of the most common types of allergy in North America, especially, in the US. The Latin American market holds the least market share; however, this market is expected to grow significantly during the forecast period 2017-2023. Europe drug allergy market is the second largest market in the globe and growing significantly. According to European Academy of Allergy and Clinical Immunology (EAACI), around 2.6% hospitalization happens due to adverse drug effects while the prevalence of drug allergy in the hospitalized patients is around 10% in the Europe. Growing awareness about various drug allergies, improving drug standards, and changing healthcare practices are leading the growth of the market in Asia Pacific.